Аnti-money laundering policy Non disclosure agreement

Project news


Jan. 6, 2022, 9:22 p.m.

Government interest is one of the key factors in the development of biotechnology and in determining its value. Today, over 40 countries have national strategies to advance the bioeconomy.

Read more

Branded T-shirts

Dec. 31, 2021, 12:26 p.m.

Dear UFG Investors and Partners! Due to your demand, we make it possible to purchase our brand T-shirts using your partner account UFG.

Read more


Dec. 24, 2021, 10 a.m.

Dear UFG Partners and Investors of SILVER, GOLD AND PLATINUM status! In gratitude for your invaluable support, unbreakable faith in the company at the very beginning of our journey and your work done, we decided send each of you a gift: 5 bottles of RUSICH balm!

Read more


Dec. 2, 2021, 7:37 a.m.

First, let's figure out what the difference is. The principles of investing in biotech and healthcare companies differ quite widely. They have different valuation techniques, they affect the investor's expenses and income in different ways, and they work differently in the long run. Despite this, there is a "gray" area where they interact closely with each other.

Read more

"AstroMelanin" Development News!!

Nov. 9, 2021, 11:47 a.m.

Preparation for tests on anti-cancer activity: the study will be carried out on several types of cancer cells using several types of melanin and Astromelanin.

Read more

Biotechnology market

Nov. 4, 2021, 5:05 p.m.

Curing complex diseases, improving the quality of life, extending it – this is what biotechnology can provide in the future. The industry is attracting more and more attention not only by the opportunity to make money on the growth of the asset's value but also by the personal interest of investors to take advantage of its achievements.

Read more

Very important!

Oct. 25, 2021, noon

In mid-October, for the first time, we independently isolated the first batch of AstroMelanin from our own raw materials.

Read more